Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Penicillamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,316Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of December 20, 2023
    Enforcement Report - Week of December 20, 2023

    20 Dec 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-20-2023-27421.pdf

    FDA
    20 Dec 2023
    Share Share
    Sun Pharma, Lupin recall drugs in US on manufacturing woes
    Sun Pharma, Lupin recall drugs in US on manufacturing woes

    18 Dec 2023

    // TIMES OF INDIA

    https://timesofindia.indiatimes.com/business/india-business/sun-pharma-lupin-recall-drugs-in-us-on-manufacturing-woes/articleshow/106069616.cms?from=mdr

    TIMES OF INDIA
    18 Dec 2023
    Share Share
    Wilson's disease treatment from Orphalan gets the go-ahead after PhIII
    Wilson's disease treatment from Orphalan gets the go-ahead after PhIII

    03 May 2022

    // J. Sullivan ENDPTS

    https://endpts.com/wilsons-disease-treatment-from-orphalan-gets-the-go-ahead-after-phiii/

    J. Sullivan ENDPTS
    03 May 2022
    Share Share
    Navinta`s Generic Penicillamine Receives Approval in US
    Navinta`s Generic Penicillamine Receives Approval in US

    14 Oct 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214363

    FDA
    14 Oct 2021
    Share Share
    Aggrega's Generic Penicillamine Receives Approval In the US
    Aggrega's Generic Penicillamine Receives Approval In the US

    23 Aug 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215409

    FDA
    23 Aug 2021
    Share Share
    Invagen Pharms' Generic Penicillamine Receives Approval in US
    Invagen Pharms' Generic Penicillamine Receives Approval in US

    19 Aug 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213293

    FDA
    19 Aug 2021
    Share Share